Formula Pharmaceuticals, located in Berwyn, PA, is a leading provider of innovative solutions in the field of nanobodies and antigen detection. Their extensive product range includes camelid nanobodies, CD4 CD8 viral chimeric antigen receptor home antigen distributors, cDNA ELISA kits, PCR assays, and malachite green phosphate assay kits. With a focus on simplicity, sensitivity, and reproducibility, Formula Pharmaceuticals offers a wide variety of applications for measuring inorganic phosphate, protein and lipid phosphorylation, phosphatase activity, and the detection of heartworm antigen, Anaplasma phagocytophilum, Anaplasma platys, Borrelia burgdorferi, and Ehrlichia canis antibodies in canine serum, plasma, or whole blood.
Additionally, Formula Pharmaceuticals provides PolymorphPrep, a ready-to-use solution for the isolation of polymorphonuclear leukocytes from undiluted human whole blood, and conducts research on the efficiency of prostate-specific antigen density measurement, identification of novel target antigens in primary membranous nephropathy, effectiveness of matching human leukocyte antigens in corneal transplantation, development of SARS-CoV-2 antigen tests using engineered affinity proteins, and the diagnostic impact of UK regional variations in age-specific prostate-specific antigen guidelines. With their commitment to advancing scientific knowledge and improving diagnostic capabilities, Formula Pharmaceuticals is at the forefront of cutting-edge research and development in the field.
Generated from the website